Translations:Lipid-lowering agent/7/ja: Difference between revisions

From Azupedia
Jump to navigation Jump to search
VisualWikitext
Created page with "==研究{{Anchor|Research}}== 高脂血症治療薬の研究クラス： * CETP阻害薬（コレステリルエステル転移蛋白）。1つの候補(アナセトラピブ)が試験中である。これらの薬物は主にHDLを増加させ、LDLを低下させることが期待されている。 * スクアレン合成酵素阻害薬 * ApoA-1ミラノ * 新規抗酸化..."
 
(No difference)

Latest revision as of 22:03, 13 April 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Lipid-lowering agent)
==Research==
Investigational classes of hypolipidemic agents:
* [[CETP inhibitor]]s (cholesteryl ester transfer protein), 1 candidate is in trials. ([[Anacetrapib]]) It is expected that these drugs will mainly increase HDL while lowering LDL
* [[Squalene synthase inhibitor]]
* [[ApoA-1 Milano]]
* Succinobucol (AGI-1067), a novel antioxidant, failed a phase-III trial.
* Apoprotein-B inhibitor [[mipomersen]] (approved by the FDA in 2013 homozygous [[familial hypercholesterolemia]].).
* [[Bempedoic acid]], an ATP citrate lyase inhibitor

研究

高脂血症治療薬の研究クラス：

Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Lipid-lowering_agent/7/ja&oldid=138975"